Health & Medicine
- Tech
Plans fizzled for nuclear-powered artificial heart
In 1965, researchers saw a nuclear-powered heart in the future.
By Beth Mole - Health & Medicine
Prospective Crohn’s drug yields high rate of remission
An experimental Crohn’s disease drug triggers a high remission rate in patients.
By Nathan Seppa - Health & Medicine
For heart repair, call RNA
Mice regrow muscle cells after heart attacks if injected with molecules mimicking RNA involved in cell growth.
- Health & Medicine
Aspirin, other painkillers may not reduce colorectal cancer risk for everybody
Aspirin and NSAIDs appear widely protective against colorectal cancer, but not for everyone.
By Nathan Seppa - Health & Medicine
In babies, turning down inflammation soothes the hurt
Babies don’t feel nerve pain because their immune systems tamp down inflammation.
- Health & Medicine
Rise in measles cases predicted in Ebola-stricken areas
Disruptions in vaccination campaigns in West Africa during the Ebola outbreak could lead to as many as 16,000 deaths from measles in the coming months.
By Nathan Seppa - Life
For healthy eating, timing matters
Limiting eating times improves heart function in fruit flies.
- Life
Chickens to blame for spread of latest deadly bird flu
Chickens are responsible for the second wave of H7N9 bird flu in China.
- Health & Medicine
Teens have higher anaphylaxis risk than younger kids
Adolescents may be more apt to experience an extreme allergic reaction than younger children, researchers report.
By Nathan Seppa - Life
Experimental herpes vaccine works in mice
An experimental herpes vaccine works in animal tests by using an approach starkly different from that used in previous vaccine development.
By Nathan Seppa - Health & Medicine
Arsenic spurs adaptation in Argentinian villagers
The people of San Antonio de los Cobres, Argentina, have genetic adaptations that may help them efficiently get rid of arsenic, a new study shows.
- Health & Medicine
Hepatitis E vaccine shows strong coverage
A large trial in China indicates that a vaccine can provide 87 percent protection against the hepatitis E virus, which infects 20 million people a year.
By Nathan Seppa